WuXi’s Toxicology Facility in Suzhou Passes FDA Inspection

The U.S. Food and Drug Administration (FDA) recently conducted a surveillance Good Laboratory Practice (GLP) inspection of WuXi's toxicology facility in Suzhou, and the facility passed with no major observations.  The inspection was extensive,...

WuXi Receives 2015 Asian CRO Company of the Year Award from Frost & Sullivan

We are thrilled to share with you that we have been awarded the 2015 Frost & Sullivan Asian CRO Company of the Year Award.  The award is part of the Frost...

WuXi Discovery Biology Receives “Excellent Partner Award”

We are honored to have received the "Excellent Partner Award" from the Lilly China Research and Development Center (LCRDC) in March 2014.  The award recognizes of the contribution of the WuXi...

WuXi Corporate Venture Fund Invests in TruTag Security Platform for Drug Safety

We are delighted to announce that WuXi Corporate Venture Fund has made an investment in TruTag.  In addition, WuXi and TruTag will explore collaborations to offer WuXi’s global customers the TruTag...

WuXi Successfully Hosts 2nd Annual WuXi Global Forum – A Video Summary

Thanks to our esteemed speakers, and great industry support and participation, WuXi Global Forum 2014 was a great success. We created a couple of short videos to capture those special and...

SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

INNOVATION THAT MATTERS

Harvard’s David Sinclair Treats Aging as a Disease and Plans to...

Harvard University’s David Sinclair, world renowned for his anti-aging research, sees no limit on human life span and is collaborating on a clinical trial...